Event Brief
Dec 11, 2025 at 10:06 PM ET
Celltrion's Avtozma biosimilar added to U.S. list
By The BriefBrief
Celltrion's Avtozma biosimilar has been included in the U.S. preferred drug list, enhancing its market presence.
WHO: Celltrion Inc.
WHAT: Avtozma biosimilar added to U.S. preferred drug list
WHEN: Dec 11, 2025 at 7:00 PM ET
WHERE: United States
WHY: To enhance market presence and accessibility of the drug
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21420 of 21420
Same format. Every time.
Continue reading — sign in or create a free account with
